Northwestern Medicine scientists have discovered two successful therapies that slowed the progression of pediatric leukemia in mice, the first step towards a pediatric leukemia “super drug.”
Browsing: Disease Discoveries
Northwestern Medicine scientists have discovered that an enzyme called EZH2 can activate expression of the androgen receptor gene, which drives prostate cancer growth.
A human protein called RBBP6 helps fight the Ebola virus by interfering with the virus replication cycle, according to a study recently published in Cell.
Inhibiting CHAF1B, a protein that normally helps replenish blood cells, may be a promising treatment for leukemia, according to a recent study.
A Northwestern Medicine study has revealed new insights into a pathway in prostate cancer and identified a potential new therapeutic target for aggressive disease.
Armed with a prestigious new grant, investigators prepare to rapidly translate scientific breakthroughs into better brain tumor therapies. Read the story in Northwestern Medicine magazine.
A Northwestern University experimental therapeutic targeting a specific protein kinase reversed neurological symptoms in a mouse genetic model of autism, according to a recent Northwestern Medicine study.
Scientists have identified a novel regulator of liver metabolism, which could serve as a potential therapeutic target for obesity, type 2 diabetes and related conditions.
Northwestern Medicine scientists have demonstrated that mitochondrial damage plays a critical early role in a group of diseases, including forms of ALS and dementia.
Inflammation has unexpected effects on body clock function and can lead to sleep and shiftwork-type disorders, according to a new study.